IMMURON LIMITED - Announcements

Market Cap $20.52M Add to my watchlist

Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Announcements

Filter Results

All Price Sensitive Only

IMC	Trading Halt	PRICE SENSITIVE	08/06/17	297.21KB	Share
IMC	Travelan Increases Industry Presence - Conf & Sales Update	PRICE SENSITIVE	02/06/17	1.12MB	Share
IMC	Immuron Secures $1.5M R&D Cash Advance Loan Funding	PRICE SENSITIVE	01/06/17	1.09MB	Share
IMC	NASDAQ Listing on Hold Pending NASH Interim Analysis Results	PRICE SENSITIVE	01/06/17	1.09MB	Share
IMC	Trading Halt	PRICE SENSITIVE	30/05/17	297.07KB	Share
IMC	IMC Expands Agreement with US Army-3 Additional Therapeutics	PRICE SENSITIVE	16/05/17	1.11MB	Share
IMC	Completion of Manufacturing of Drug Product for C-Diff Trial	PRICE SENSITIVE	10/05/17	1.11MB	Share
IMC	Immuron - New Investor Corporate Presentation (May 2017)		09/05/17	6.66MB	Share
IMC	IMC Form F1 - US Registration Statement (Prelim. Prospectus)	PRICE SENSITIVE	09/05/17	1MB	Share
IMC	Immuron Files Amended Form F-1 and New Investor Presentation		09/05/17	1.07MB	Share
IMC	Form 604 - Change in Substantial Shareholding (Authentics)		05/05/17	102.57KB	Share
IMC	Form 603 - Initial Substantial Shareholder (Authentics)		05/05/17	100.46KB	Share
IMC	Positive Results of IMM-124E in Acute Colitis Studies	PRICE SENSITIVE	18/04/17	1.23MB	Share
IMC	Immuron Update on US Listing - Proceeding as Planned		11/04/17	422.66KB	Share
IMC	Immuron Update on Listing - Process Proceeding as Planned		11/04/17	104.08KB	Share
IMC	Immuron Files Amended Form F-1 with the SEC		10/04/17	2.03MB	Share
IMC	Director Appointment - Prof. Ravi Savarirayan		07/04/17	255.22KB	Share
IMC	Close of Recruitment of Phase II NASH Trial	PRICE SENSITIVE	06/04/17	426.2KB	Share
IMC	Appendix 4D - Half Year Report and Accounts - Dec 2016	PRICE SENSITIVE	28/02/17	1.22MB	Share
IMC	Immuron Completes Phase II NASH Clinical Trial Recruitment	PRICE SENSITIVE	20/02/17	1.08MB	Share
IMC	Immuron Files Amended Form F-1 with the SEC		09/02/17	1.58MB	Share
IMC	First Patient in Pediatric Fatty-Liver Phase II Trial	PRICE SENSITIVE	06/02/17	432.48KB	Share
IMC	NASH MOA Study commences with SanyalBio & Duke University	PRICE SENSITIVE	19/01/17	464.37KB	Share
IMC	European/US Analyst - Immuron Moving to Forefront in NASH		18/01/17	87.06KB	Share
IMC	Gilead Pays $100M NASH Related Milestone to Phenex		09/01/17	115KB	Share
IMC	JNJ, BMS and Novartis Complete NASH Asset Transactions		06/01/17	102.66KB	Share
IMC	Immuron Files Form F-1 with the SEC		22/12/16	1.98MB	Share
IMC	Appendix 3B - Issue of Options Under ESOP		09/12/16	210.02KB	Share
IMC	Form 604 - Change in Substantial Shareholding (Grandlodge)		07/12/16	46.42KB	Share
IMC	Appendix 3Y - Change of Director's Interest Notices (x4)		02/12/16	1.47MB	Share
IMC	Appendix 3B - Issue of Rights Issue Options & ESOP Shares		02/12/16	193.93KB	Share
IMC	Results of 2016 Annual General Meeting		29/11/16	392.61KB	Share
IMC	2016 AGM Presentation		29/11/16	1.23MB	Share
IMC	Immuron Receives $1.6M R&D Tax Concession Refund	PRICE SENSITIVE	29/11/16	87.12KB	Share
IMC	Notice of 2016 Annual General Meeting-IMC.AX		28/10/16	283.41KB	Share
IMC	Immurons NASH Phase II Trial Achieves 100 Patient Milestone-IMC.AX	PRICE SENSITIVE	28/10/16	108.59KB	Share
IMC	Appendix 3Y - Change in Director's Interest Notice (DP)-IMC.AX		27/10/16	376.95KB	Share
IMC	Becoming a substantial holder-IMC.AX		17/10/16	56.59KB	Share
IMC	NASH Phase II Trial reaches 75% of Patient Recruitment-IMC.AX	PRICE SENSITIVE	10/10/16	112.49KB	Share
IMC	NASH Assets In Demand - Allergan Acquires Tobira for US$1.7B-IMC.AX		05/10/16	105.86KB	Share
IMC	IMC - ASX - Appendix 3B (Rights Issue)-IMC.AX		04/10/16	169.14KB	Share
IMC	Immurons $6M Rights Issue Closes Oversubscribed-IMC.AX	PRICE SENSITIVE	04/10/16	98.8KB	Share
IMC	Appendix 4E and Annual Report-IMC.AX	PRICE SENSITIVE	30/08/16	2.09MB	Share
IMC	Appendix 4G-IMC.AX		30/08/16	356.91KB	Share
IMC	Immuron Expands Collaborate with US Navy-IMC.AX	PRICE SENSITIVE	30/08/16	467.6KB	Share
IMC	US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH-IMC.AX	PRICE SENSITIVE	18/08/16	119.14KB	Share
IMC	Travelan to be Stocked by US Distributor Medique Products-IMC.AX	PRICE SENSITIVE	08/08/16	99.33KB	Share
IMC	Immuron to Seek Approval of Rights Issue Options at AGM-IMC.AX		02/08/16	89.19KB	Share
IMC	Immuron to Cooperate with Universities on Autism Research-IMC.AX	PRICE SENSITIVE	20/07/16	453.37KB	Share
IMC	Immuron to repay outstanding Convertible Note in cash-IMC.AX	PRICE SENSITIVE	18/07/16	97.72KB	Share
IMC	Form 604 -Change in Substantial Shareholding (Inverarey P/L)-IMC.AX		15/07/16	74.01KB	Share
IMC	Appendix 3Y - Change in Director's Interest Notices (x4)-IMC.AX		11/07/16	89.88KB	Share
IMC	Appendix 3B for Rights Issue & New Top 20 Shareholder List-IMC.AX		07/07/16	215.59KB	Share
IMC	Immuron Rights Issue Raises $5.33M-IMC.AX		05/07/16	104.15KB	Share
IMC	IMC Signs Shigella Vaccine Developmt Agreement with US Army-IMC.AX	PRICE SENSITIVE	21/06/16	103.13KB	Share
IMC	Immuron Newsletter - June 2016-IMC.AX		20/06/16	2.02MB	Share
IMC	Travelan and Protectyn Are Now Available For Sale in China-IMC.AX	PRICE SENSITIVE	16/06/16	313.17KB	Share
IMC	Immuron Extends Closing Date of $6M Rights Issue-IMC.AX		14/06/16	80.88KB	Share
IMC	Travelan to Reach Upto 1.5M New US Customers via Magellans-IMC.AX	PRICE SENSITIVE	14/06/16	92.21KB	Share
IMC	Immuron Company Presentation - May 2016-IMC.AX		31/05/16	3.19MB	Share
IMC	Immuron Rights Issue Offer Booklet (May 2016)-IMC.AX	PRICE SENSITIVE	31/05/16	315.95KB	Share
IMC	Letter to Ineligible Shareholders Regarding Rights Issue-IMC.AX		31/05/16	98.03KB	Share
IMC	Letter to Eligible Shareholders Regarding Rights Issue-IMC.AX		31/05/16	98.63KB	Share
IMC	Letter to Optionholders Regarding Rights Issue (May 2016)-IMC.AX		31/05/16	98.43KB	Share
IMC	Section 708AA Notice (Rights Issue)-IMC.AX		31/05/16	108.05KB	Share
IMC	Appendix 3B & 708A Notice-IMC.AX		31/05/16	185.86KB	Share
IMC	Immuron Announces $6M Rights Issue Offer-IMC.AX	PRICE SENSITIVE	31/05/16	140.58KB	Share
IMC	Trading halt-IMC.AX	PRICE SENSITIVE	27/05/16	133.42KB	Share
IMC	NASH Phase II Trial Reaches 50% Recruitment Milestone-IMC.AX	PRICE SENSITIVE	25/05/16	92.52KB	Share
IMC	Appendix 3B & 708A Notice-IMC.AX		16/05/16	180.24KB	Share
IMC	Immuron Announces E-Commerce Agreement with QBID in China-IMC.AX	PRICE SENSITIVE	09/05/16	114.05KB	Share
IMC	US Distribution Reach Expanded through McKesson-IMC.AX	PRICE SENSITIVE	28/04/16	403.5KB	Share
IMC	US Travelan Sales Network Widened by Allocation Inc Ptnrship-IMC.AX	PRICE SENSITIVE	19/04/16	105.28KB	Share
IMC	Appendix 3B & 708A Notice-IMC.AX		18/04/16	181.31KB	Share
IMC	Expansion of US Travelan Sales Following CVS Pharmacy Launch-IMC.AX	PRICE SENSITIVE	14/04/16	102.8KB	Share
IMC	Appendix 3B - Issuance of Securities-IMC.AX		13/04/16	187.97KB	Share
IMC	Appendix 4D - Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/16	1.67MB	Share
IMC	Appendix 3B - Issue of Securities		24/02/16	183.01KB	Share
IMC	Immuron Initiates Pre-Clinical Colitis Development Program	PRICE SENSITIVE	22/02/16	100.49KB	Share
IMC	Immuron Secures upto $1.7M Equity & Convertible Note Funding	PRICE SENSITIVE	17/02/16	99.71KB	Share
IMC	Immuron Receives $1.47M R&D Tax Concession Refund	PRICE SENSITIVE	04/02/16	83.71KB	Share
IMC	US Analyst Reports on Immuron Products and R&D Pipeline		03/02/16	82.61KB	Share
IMC	Analyst Reports on Immuron IMM-529 C. difficile Program	PRICE SENSITIVE	14/01/16	89.67KB	Share
IMC	IMC Achieves Outstanding Results in C-Diff Recurrence Study	PRICE SENSITIVE	12/01/16	116.44KB	Share
IMC	IMC Reports Highly Successful C-Diff Pre-Clinical Results	PRICE SENSITIVE	22/12/15	115.8KB	Share
IMC	Appendix 3B		04/12/15	178.12KB	Share
IMC	Change of Director's Interest Notices x4 - (RA, PA, DP, SA)		04/12/15	681.01KB	Share
IMC	Results of 2015 Immuron Annual General Meeting		25/11/15	245.94KB	Share
IMC	Immuron 2015 Annual General Meeting Presentation		25/11/15	1.09MB	Share
IMC	NASH Clinical Trial Surpasses 25% Patient Recruitment Level	PRICE SENSITIVE	18/11/15	95.33KB	Share
IMC	IMC Signs US Travelan Sales Agreement with Medico-Mart Inc	PRICE SENSITIVE	12/11/15	90.51KB	Share
IMC	Replay of Immuron CEO's Presentation at Microcap Conference		10/11/15	73.21KB	Share
IMC	Appendix 3B - Exercise of Options		09/11/15	552.85KB	Share
IMC	NASH Diagnostic Collaboration Agreement - OWL Metabolomics	PRICE SENSITIVE	09/11/15	104.29KB	Share
IMC	IMC Signs US Travelan Sales P/ship with TravelCare WorldWide		05/11/15	92.94KB	Share
IMC	Notice of Annual General Meeting & Explanatory Memorandum		28/10/15	842.29KB	Share
IMC	Passport Health - Sales Partnership Agreement	PRICE SENSITIVE	26/10/15	307.82KB	Share
IMC	Change of Director's Interest Notice - (PA)		23/10/15	248.59KB	Share
IMC	IMC to Present at RedChip Global Online Microcap Conference		22/10/15	2.99MB	Share
IMC	604 Change of Substantial Shareholder Interest (Grandlodge)		21/10/15	200.11KB	Share

IMC Trading Halt
08/06/17	PRICE SENSITIVE	297.21KB	Share
IMC Travelan Increases Industry Presence - Conf & Sales Update
02/06/17	PRICE SENSITIVE	1.12MB	Share
IMC Immuron Secures $1.5M R&D Cash Advance Loan Funding
01/06/17	PRICE SENSITIVE	1.09MB	Share
IMC NASDAQ Listing on Hold Pending NASH Interim Analysis Results
01/06/17	PRICE SENSITIVE	1.09MB	Share
IMC Trading Halt
30/05/17	PRICE SENSITIVE	297.07KB	Share
IMC IMC Expands Agreement with US Army-3 Additional Therapeutics
16/05/17	PRICE SENSITIVE	1.11MB	Share
IMC Completion of Manufacturing of Drug Product for C-Diff Trial
10/05/17	PRICE SENSITIVE	1.11MB	Share
IMC Immuron - New Investor Corporate Presentation (May 2017)
09/05/17		6.66MB	Share
IMC IMC Form F1 - US Registration Statement (Prelim. Prospectus)
09/05/17	PRICE SENSITIVE	1MB	Share
IMC Immuron Files Amended Form F-1 and New Investor Presentation
09/05/17		1.07MB	Share
IMC Form 604 - Change in Substantial Shareholding (Authentics)
05/05/17		102.57KB	Share
IMC Form 603 - Initial Substantial Shareholder (Authentics)
05/05/17		100.46KB	Share
IMC Positive Results of IMM-124E in Acute Colitis Studies
18/04/17	PRICE SENSITIVE	1.23MB	Share
IMC Immuron Update on US Listing - Proceeding as Planned
11/04/17		422.66KB	Share
IMC Immuron Update on Listing - Process Proceeding as Planned
11/04/17		104.08KB	Share
IMC Immuron Files Amended Form F-1 with the SEC
10/04/17		2.03MB	Share
IMC Director Appointment - Prof. Ravi Savarirayan
07/04/17		255.22KB	Share
IMC Close of Recruitment of Phase II NASH Trial
06/04/17	PRICE SENSITIVE	426.2KB	Share
IMC Appendix 4D - Half Year Report and Accounts - Dec 2016
28/02/17	PRICE SENSITIVE	1.22MB	Share
IMC Immuron Completes Phase II NASH Clinical Trial Recruitment
20/02/17	PRICE SENSITIVE	1.08MB	Share
IMC Immuron Files Amended Form F-1 with the SEC
09/02/17		1.58MB	Share
IMC First Patient in Pediatric Fatty-Liver Phase II Trial
06/02/17	PRICE SENSITIVE	432.48KB	Share
IMC NASH MOA Study commences with SanyalBio & Duke University
19/01/17	PRICE SENSITIVE	464.37KB	Share
IMC European/US Analyst - Immuron Moving to Forefront in NASH
18/01/17		87.06KB	Share
IMC Gilead Pays $100M NASH Related Milestone to Phenex
09/01/17		115KB	Share
IMC JNJ, BMS and Novartis Complete NASH Asset Transactions
06/01/17		102.66KB	Share
IMC Immuron Files Form F-1 with the SEC
22/12/16		1.98MB	Share
IMC Appendix 3B - Issue of Options Under ESOP
09/12/16		210.02KB	Share
IMC Form 604 - Change in Substantial Shareholding (Grandlodge)
07/12/16		46.42KB	Share
IMC Appendix 3Y - Change of Director's Interest Notices (x4)
02/12/16		1.47MB	Share
IMC Appendix 3B - Issue of Rights Issue Options & ESOP Shares
02/12/16		193.93KB	Share
IMC Results of 2016 Annual General Meeting
29/11/16		392.61KB	Share
IMC 2016 AGM Presentation
29/11/16		1.23MB	Share
IMC Immuron Receives $1.6M R&D Tax Concession Refund
29/11/16	PRICE SENSITIVE	87.12KB	Share
IMC Notice of 2016 Annual General Meeting-IMC.AX
28/10/16		283.41KB	Share
IMC Immurons NASH Phase II Trial Achieves 100 Patient Milestone-IMC.AX
28/10/16	PRICE SENSITIVE	108.59KB	Share
IMC Appendix 3Y - Change in Director's Interest Notice (DP)-IMC.AX
27/10/16		376.95KB	Share
IMC Becoming a substantial holder-IMC.AX
17/10/16		56.59KB	Share
IMC NASH Phase II Trial reaches 75% of Patient Recruitment-IMC.AX
10/10/16	PRICE SENSITIVE	112.49KB	Share
IMC NASH Assets In Demand - Allergan Acquires Tobira for US$1.7B-IMC.AX
05/10/16		105.86KB	Share
IMC IMC - ASX - Appendix 3B (Rights Issue)-IMC.AX
04/10/16		169.14KB	Share
IMC Immurons $6M Rights Issue Closes Oversubscribed-IMC.AX
04/10/16	PRICE SENSITIVE	98.8KB	Share
IMC Appendix 4E and Annual Report-IMC.AX
30/08/16	PRICE SENSITIVE	2.09MB	Share
IMC Appendix 4G-IMC.AX
30/08/16		356.91KB	Share
IMC Immuron Expands Collaborate with US Navy-IMC.AX
30/08/16	PRICE SENSITIVE	467.6KB	Share
IMC US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH-IMC.AX
18/08/16	PRICE SENSITIVE	119.14KB	Share
IMC Travelan to be Stocked by US Distributor Medique Products-IMC.AX
08/08/16	PRICE SENSITIVE	99.33KB	Share
IMC Immuron to Seek Approval of Rights Issue Options at AGM-IMC.AX
02/08/16		89.19KB	Share
IMC Immuron to Cooperate with Universities on Autism Research-IMC.AX
20/07/16	PRICE SENSITIVE	453.37KB	Share
IMC Immuron to repay outstanding Convertible Note in cash-IMC.AX
18/07/16	PRICE SENSITIVE	97.72KB	Share
IMC Form 604 -Change in Substantial Shareholding (Inverarey P/L)-IMC.AX
15/07/16		74.01KB	Share
IMC Appendix 3Y - Change in Director's Interest Notices (x4)-IMC.AX
11/07/16		89.88KB	Share
IMC Appendix 3B for Rights Issue & New Top 20 Shareholder List-IMC.AX
07/07/16		215.59KB	Share
IMC Immuron Rights Issue Raises $5.33M-IMC.AX
05/07/16		104.15KB	Share
IMC IMC Signs Shigella Vaccine Developmt Agreement with US Army-IMC.AX
21/06/16	PRICE SENSITIVE	103.13KB	Share
IMC Immuron Newsletter - June 2016-IMC.AX
20/06/16		2.02MB	Share
IMC Travelan and Protectyn Are Now Available For Sale in China-IMC.AX
16/06/16	PRICE SENSITIVE	313.17KB	Share
IMC Immuron Extends Closing Date of $6M Rights Issue-IMC.AX
14/06/16		80.88KB	Share
IMC Travelan to Reach Upto 1.5M New US Customers via Magellans-IMC.AX
14/06/16	PRICE SENSITIVE	92.21KB	Share
IMC Immuron Company Presentation - May 2016-IMC.AX
31/05/16		3.19MB	Share
IMC Immuron Rights Issue Offer Booklet (May 2016)-IMC.AX
31/05/16	PRICE SENSITIVE	315.95KB	Share
IMC Letter to Ineligible Shareholders Regarding Rights Issue-IMC.AX
31/05/16		98.03KB	Share
IMC Letter to Eligible Shareholders Regarding Rights Issue-IMC.AX
31/05/16		98.63KB	Share
IMC Letter to Optionholders Regarding Rights Issue (May 2016)-IMC.AX
31/05/16		98.43KB	Share
IMC Section 708AA Notice (Rights Issue)-IMC.AX
31/05/16		108.05KB	Share
IMC Appendix 3B & 708A Notice-IMC.AX
31/05/16		185.86KB	Share
IMC Immuron Announces $6M Rights Issue Offer-IMC.AX
31/05/16	PRICE SENSITIVE	140.58KB	Share
IMC Trading halt-IMC.AX
27/05/16	PRICE SENSITIVE	133.42KB	Share
IMC NASH Phase II Trial Reaches 50% Recruitment Milestone-IMC.AX
25/05/16	PRICE SENSITIVE	92.52KB	Share
IMC Appendix 3B & 708A Notice-IMC.AX
16/05/16		180.24KB	Share
IMC Immuron Announces E-Commerce Agreement with QBID in China-IMC.AX
09/05/16	PRICE SENSITIVE	114.05KB	Share
IMC US Distribution Reach Expanded through McKesson-IMC.AX
28/04/16	PRICE SENSITIVE	403.5KB	Share
IMC US Travelan Sales Network Widened by Allocation Inc Ptnrship-IMC.AX
19/04/16	PRICE SENSITIVE	105.28KB	Share
IMC Appendix 3B & 708A Notice-IMC.AX
18/04/16		181.31KB	Share
IMC Expansion of US Travelan Sales Following CVS Pharmacy Launch-IMC.AX
14/04/16	PRICE SENSITIVE	102.8KB	Share
IMC Appendix 3B - Issuance of Securities-IMC.AX
13/04/16		187.97KB	Share
IMC Appendix 4D - Half Yearly Report and Accounts
25/02/16	PRICE SENSITIVE	1.67MB	Share
IMC Appendix 3B - Issue of Securities
24/02/16		183.01KB	Share
IMC Immuron Initiates Pre-Clinical Colitis Development Program
22/02/16	PRICE SENSITIVE	100.49KB	Share
IMC Immuron Secures upto $1.7M Equity & Convertible Note Funding
17/02/16	PRICE SENSITIVE	99.71KB	Share
IMC Immuron Receives $1.47M R&D Tax Concession Refund
04/02/16	PRICE SENSITIVE	83.71KB	Share
IMC US Analyst Reports on Immuron Products and R&D Pipeline
03/02/16		82.61KB	Share
IMC Analyst Reports on Immuron IMM-529 C. difficile Program
14/01/16	PRICE SENSITIVE	89.67KB	Share
IMC IMC Achieves Outstanding Results in C-Diff Recurrence Study
12/01/16	PRICE SENSITIVE	116.44KB	Share
IMC IMC Reports Highly Successful C-Diff Pre-Clinical Results
22/12/15	PRICE SENSITIVE	115.8KB	Share
IMC Appendix 3B
04/12/15		178.12KB	Share
IMC Change of Director's Interest Notices x4 - (RA, PA, DP, SA)
04/12/15		681.01KB	Share
IMC Results of 2015 Immuron Annual General Meeting
25/11/15		245.94KB	Share
IMC Immuron 2015 Annual General Meeting Presentation
25/11/15		1.09MB	Share
IMC NASH Clinical Trial Surpasses 25% Patient Recruitment Level
18/11/15	PRICE SENSITIVE	95.33KB	Share
IMC IMC Signs US Travelan Sales Agreement with Medico-Mart Inc
12/11/15	PRICE SENSITIVE	90.51KB	Share
IMC Replay of Immuron CEO's Presentation at Microcap Conference
10/11/15		73.21KB	Share
IMC Appendix 3B - Exercise of Options
09/11/15		552.85KB	Share
IMC NASH Diagnostic Collaboration Agreement - OWL Metabolomics
09/11/15	PRICE SENSITIVE	104.29KB	Share
IMC IMC Signs US Travelan Sales P/ship with TravelCare WorldWide
05/11/15		92.94KB	Share
IMC Notice of Annual General Meeting & Explanatory Memorandum
28/10/15		842.29KB	Share
IMC Passport Health - Sales Partnership Agreement
26/10/15	PRICE SENSITIVE	307.82KB	Share
IMC Change of Director's Interest Notice - (PA)
23/10/15		248.59KB	Share
IMC IMC to Present at RedChip Global Online Microcap Conference
22/10/15		2.99MB	Share
IMC 604 Change of Substantial Shareholder Interest (Grandlodge)
21/10/15		200.11KB	Share

REFRESH

First 3 4 5 6 7

(20min delay)
Last 9.0¢		Change 0.000(0.00%)		Mkt cap ! $20.52M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	30000	9.0¢

Sellers (Offers)

Price($)	Vol.	No.
9.5¢	9000	1

View Market Depth

No.	Vol.	Price($)
1	30000	0.090
1	31751	0.089
2	233688	0.088
1	9309	0.087
1	35000	0.085

Price($)	Vol.	No.
0.095	9000	1
0.098	5714	1
0.100	119000	4
0.105	140757	6
0.110	200000	2

Last trade - 09.04am 22/05/2024 (20 minute delay)

IMC (ASX) Chart

Day chart unavailable

IMMURON LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories